Life SciencesLiability
Get a quote

TL;DR

Indianapolis is one of the country's notable diagnostics and in-vitro diagnostics centers, anchored by Roche Diagnostics' North American headquarters and a surrounding cluster of diagnostic-instrument and IVD companies. Insurance for these firms has to blend device and product exposures with laboratory, professional, and health-data risk in a single program. We structure products liability for diagnostic instruments and IVD products, professional liability for diagnostic accuracy, cyber sized to protected health information, and the FDA, CLIA, and hospital-contract requirements that govern the sector.

Indianapolis diagnostics

Diagnostics Insurance for Indianapolis and Central Indiana

Indianapolis occupies an unusual position in American life sciences: it is a genuine diagnostics and in-vitro diagnostics hub, not simply an extension of its better-known pharmaceutical base. Roche Diagnostics operates its North American headquarters in the metro, and that presence anchors a cluster of diagnostic-instrument makers, IVD developers, and laboratory-service operations across Central Indiana. This diagnostics profile is distinct from the region's pharmaceutical manufacturing, which we address on a separate page, and it calls for a different risk architecture.

A diagnostics company rarely fits a single insurance template. The same business may design and sell an analyzer, manufacture the reagents and assays that run on it, and in some cases perform the testing itself. That combination fuses product-manufacturing exposure, laboratory and professional exposure, and large-volume health-data exposure into one operation. We build Indianapolis diagnostics programs that treat those layers as a coordinated whole rather than as disconnected policies with gaps between them.

Get a quoteRun the Free Analyzer

Last updated 2026-07-13

Cluster shape

The Indianapolis diagnostics cluster

The metro's diagnostics identity is defined by instrument and IVD activity. With Roche Diagnostics' North American headquarters anchoring the region, Indianapolis supports diagnostic-instrument design, assay and reagent development, and the specialized supply chains that feed clinical and reference laboratories nationwide. That concentration draws vendors, contract developers, and downstream testing operations into the same ecosystem.

Because diagnostics sits at the intersection of hardware, chemistry, software, and clinical interpretation, the companies in this cluster carry a wider mix of exposures than most life-sciences firms. An instrument is a manufactured product; an IVD assay is a regulated product with clinical consequences; a laboratory service is a professional activity; and every patient result is health data. Underwriters read these operations very differently depending on which of those roles a given company actually performs.

For an Indianapolis diagnostics company, the practical challenge is proving where its exposure begins and ends. A firm that only sells instruments to hospitals looks nothing like one that also runs a CLIA-certified testing laboratory. We map each company's real activities before placing coverage so the program reflects its actual class, clinical use, and data footprint rather than a generic diagnostics label.

Coverage architecture

How we structure diagnostics coverage

Products liability is the backbone. We size it to the class and clinical use of each diagnostic instrument and IVD product, recognizing that a benchtop analyzer, a companion diagnostic, and a point-of-care assay present materially different loss profiles. Where a company also provides testing services, we add professional liability for diagnostic accuracy so that an error in interpretation or reporting is covered alongside a defect in the product itself. Market-typical limits for diagnostics products and professional lines commonly run in the single-digit to low-tens-of-millions range, calibrated to revenue, class, and contract demands rather than a fixed figure.

Cyber is not an afterthought in this sector. Diagnostics firms hold large volumes of protected health information and health data, and we size cyber and privacy coverage to that volume and sensitivity, coordinating it with the technology and professional exposures the business already carries. For IVD products, we treat product recall as a separate first-party trigger, so the direct costs of withdrawing or correcting a distributed assay or instrument are addressed distinctly from third-party liability.

Diagnostics companies also live inside their customers' contracts. Hospital, reference-laboratory, and group-purchasing-organization agreements routinely require additional-insured status for both products and completed operations, along with specific limits and waiver language. We align the certificate and policy structure to those purchase contracts so that additional-insured, completed-operations, and vendor obligations are met without leaving the manufacturer over-exposed. Placement is with A-rated specialty markets that understand the device-and-data blend these accounts present.

Regulatory + market context

Regulatory and contractual context

Indianapolis diagnostics companies are governed first by the FDA IVD and device regulatory pathway, which determines how a given product is classified and cleared and, in turn, how underwriters view its clinical risk. For operations that perform laboratory testing, CLIA under 42 CFR Part 493 sets the certification and quality standards that a professional-liability program must reflect. The regulatory posture of a company is a direct input to how we structure products and professional coverage.

Customer contracts add a second layer of requirement that is just as binding in practice. Hospital and reference-laboratory purchase agreements and GPO contracts frequently dictate additional-insured status for products and completed operations, minimum limits, and indemnity terms. We read those obligations against the placed program so that regulatory standing and contractual insurance requirements are satisfied together, not in isolation.

Frequently asked

Common questions from Indianapolis diagnostics operators

What makes Indianapolis diagnostics insurance distinct from other life-sciences coverage in the region?

Indianapolis is a genuine diagnostics and in-vitro diagnostics center, anchored by Roche Diagnostics' North American headquarters, and its diagnostics profile is separate from the metro's pharmaceutical presence, which we cover on its own page. Diagnostics firms combine device and product exposure with laboratory, professional, and health-data risk in a way that pharmaceutical manufacturers typically do not. That blend is why we build a coordinated program rather than a standard products policy.

How is products liability sized for diagnostic instruments and IVD products?

We size products liability to the class and clinical use of each product, since a benchtop analyzer, a companion diagnostic, and a point-of-care assay carry very different loss profiles. Instruments are underwritten as manufactured devices, while IVD assays are underwritten for their clinical consequence if a result is wrong. Limits are set to revenue, class, and contract requirements, with product recall handled as a separate first-party trigger for IVD products.

Why is cyber sized to health-data volume for diagnostics companies?

Diagnostics firms process and retain large volumes of protected health information and other health data, so the potential cost of a breach scales with the volume and sensitivity of records held. We size cyber and privacy coverage to that data footprint and coordinate it with the professional and technology exposures the business already carries. A generic cyber limit rarely matches the true exposure of a high-throughput diagnostics operation.

How do CLIA and hospital or reference-laboratory contracts affect the program?

If a company performs testing, CLIA under 42 CFR Part 493 sets the certification and quality standards that its professional-liability coverage must reflect, alongside the FDA IVD and device pathway that governs its products. Hospital, reference-laboratory, and GPO purchase contracts commonly require additional-insured status for products and completed operations, plus specified limits and waivers. We align the policy and certificate structure to both the regulatory standing and those contractual demands so the account stays compliant and adequately protected.

Diagnostic lab insurance practice →Lab cyber insurance →Indianapolis pharma insurance →Medical device insurance practice →

Free coverage review

A specialist will reach out by end of business day.

Programs placed through A-rated specialty markets. Send your contract, insurance schedule, or current COI - a specialist returns a clause-by-clause read by end of business day.

Get my quote

Specifically for Indianapolis diagnostics operators.

Programs placed through A-rated specialty markets. Your specialist handles unlimited certificates of insurance, annual coverage reviews, and claims advocacy.